Real-world evidence that drives commercial performance across your oncology portfolio
Commercial oncology leaders use Flatiron’s EHR-derived real-world data to see exactly how therapies are performing in the market with the clarity, speed, and depth that claims and survey data simply can't match.
Drive smarter actions and maximize impact by understanding market dynamics and clinical decisions.
What’s happening?
Understand market dynamics
Track launch by market segment to see how different therapies are being adopted and where uptake might be accelerating or stalling.
Why is it happening?
Understand clinical decisions
Gain insight into the market dynamics behind treatment choices — adoption patterns, switching trends, and the clinical context shaping decisions — sourced from real-world documentation.
What comes next?
Decide faster, lead the market
Use those insights to sharpen your planning, targeting, and commercial execution while you still have time to act.
Confident commercial strategies start with real-world clarity
High-fidelity RWD
Develop real-world evidence based on longitudinal, EHR-derived clinical data captured at the point of care across a unified global provider network.
Access critical market intelligence via Flatiron Telescope, our AI-powered insights platform enabling commercial teams to turn data into decisions faster than ever before.
